Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice

被引：36

作者：

McLaughlin, PJ

Levin, RJ

Zagon, IS

机构：

[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosci, Hershey, PA 17033 USA

[2] Penn State Univ, Milton S Hershey Med Ctr, Dept Anat, Hershey, PA 17033 USA

[3] Penn State Univ, Milton S Hershey Med Ctr, Dept Surg, Hershey, PA 17033 USA

来源：

CANCER LETTERS | 2003年 / 199卷 / 02期

关键词：

opioid growth factors; squamous cell carcinoma; cancer; head and neck neoplasia; odpioids; transplantation;

D O I：

10.1016/S0304-3835(03)00341-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Opioid growth factor (OGF) interacts with the OGF receptor (OGFr) and serves as a native inhibitory growth factor. OGF and OGFr are present in squamous cell carcinoma of the head and neck (SCCHN), and OGF represses the replication of SCCHN in tissue culture. In this study, OGF-treated nude mice with xenografts of SCCHN displayed delays in tumor appearance and had reduced tumor size compared to controls. OGF activity was receptor-mediated. Opioid-receptor blockade by the potent opioid antagonist, naltrexone, stimulated tumorigenic processes. Both OGF and OGFr were detected in the tumors by immunohistochemistry, and OGFr was characterized by receptor binding, analysis. These results indicate that the OGF-OGFr axis functions in vivo, OGF is a Constitutively active molecule, and OGF modulation of SCCHN may have clinical application. (C) 2003 Elsevier Ireland Ltd. All rights reserved.

引用

页码：209 / 217

页数：9

共 50 条

[21] INDUCTION OF SQUAMOUS-CELL CARCINOMA IN HUMAN BRONCHI TRANSPLANTED INTO NUDE-MICE
SHIMOSATO, Y
KODAMA, T
TAMAI, S
KAMEYA, T
GANN, 1980, 71 (03): : 402 - 407
[22] INTERFERON INHIBITS THE INVITRO GROWTH OF HUMAN HEAD AND NECK SQUAMOUS CARCINOMA CELL-LINES
LESTER, EP
CLINICAL RESEARCH, 1990, 38 (04): : A946 - A946
[23] (-)-Gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo
Wolter, Keith G.
Wang, Steven J.
Henson, Bradley S.
Wang, Shaomeng
Griffith, Kent A.
Kumar, Bhavna
Chen, Jianyong
Carey, Thomas E.
Bradford, Carol R.
D'Silva, Nisha J.
NEOPLASIA, 2006, 8 (03): : 163 - 172
[24] SURAMIN ACTIVIY IN HUMAN HEAD AND NECK SQUAMOUS CELL CARCINOMA——Ⅱ.EFFECT OF SURAMIN ON HUMAN HEAD AND NECK CARCINOMA XENOGRAFTS AND RELATED TOXICITY AND PHARMACOKINETIC STUDIES IN NUDE MICE
李安太
王天铎
栾信庸
姜玉芳
G.A.M.S.Van Dongen
B.J.M.Braakhuis
G.B.Snow
山东医科大学学报, 1992, (04) : 343 - 348
[25] Expression of the opioid growth factor, [Met(5)] - Enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma
Levin, RJ
Wu, Y
McLaughlin, PJ
Zagon, IS
LARYNGOSCOPE, 1997, 107 (03): : 335 - 339
[26] Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck
Jeffrey R. Jaglowski
Ian S. Zagon
Brendan C. Stack
Michael F. Verderame
Alphonse E. Leure-duPree
Jeffrey D. Manning
Patricia J. McLaughlin
Cancer Chemotherapy and Pharmacology, 2005, 56 : 97 - 104
[27] Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck
Jaglowski, JR
Zagon, IS
Stack, BC
Verderame, MF
Leure-duPree, AE
Manning, JD
McLaughlin, PJ
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (01) : 97 - 104
[28] HISTOPATHOLOGICAL CHARACTERISTICS PREDICTIVE FOR GROWTH OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK AFTER HETEROTRANSPLANTATION TO NUDE-MICE
WENNERBERG, J
WILLEN, R
BIORKLUND, A
TROPE, C
ANTICANCER RESEARCH, 1985, 5 (06) : 601 - 601
[29] Molecular progression of head and neck squamous cell carcinoma
Saha S.K.
Maiti G.P.
Roychoudhury S.
Panda C.K.
The Nucleus, 2017, 60 (2) : 111 - 119
[30] Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma
Nakashima, T
Hudson, JM
Clayman, GL
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (05): : 483 - 488

← 1 2 3 4 5 →